









市場
/
株式
/
nasdaq-telo
/

Telomir Pharmaceuticals Inc

TELO

1.841USD

+0.081+4.59%

取引時間（ET）15分遅れの株価

54.78M時価総額

損失額直近12ヶ月PER



Telomir Pharmaceuticals Inc

1.841

+0.081+4.59%

概要企業名金融

Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of TELOMIR-1, a novel small molecule designed to lengthen the DNA’s protective telomere caps, thereby promoting longevity in humans and canine animals by treating age-related conditions. TELOMIR-1 is undergoing studies to provide a therapeutic intervention against contracting a number of degenerative and age-related diseases. Its Telomir-1, is being investigated for its potential to address a range of conditions, including Type 2 diabetes, Wilson’s disease, progeria, Alzheimer’s disease, and cancer. The Company is focused on developing and commercializing TELOMIR-1, proposed to be dosed orally, with the aim of promoting longevity and enhancing overall quality of life. It is being developed to protect stem cells by elongating and stimulating the telomeres to sustain self-renewal.

企業情報

企業コードTELO

会社名Telomir Pharmaceuticals Inc

上場日Feb 09, 2024

最高経営責任者「CEO」Mr. Erez Aminov

従業員数- -

証券種類Ordinary Share

決算期末Feb 09

本社所在地900 West Platt Street, Suite 200

都市TAMPA

証券取引所NASDAQ Capital Market Consolidated

国United States of America

郵便番号33606

電話番号18138642562

ウェブサイトhttps://telomirpharma.com/

企業コードTELO

上場日Feb 09, 2024

最高経営責任者「CEO」Mr. Erez Aminov

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Erez Aminov

Chairman of the Board, Chief Executive Officer

1.01M

+3288.20%

Mr. Craig Eagle, M.D.

Independent Director

487.81K

Dr. Matthew P. Del Giudice

Director

Mr. Ned Macpherson

Director

Mr. Matthew Pratt Whalen, CPA

Director

Mr. Alan Weichselbaum

Chief Financial Officer

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Erez Aminov

Chairman of the Board, Chief Executive Officer

1.01M

+3288.20%

Mr. Craig Eagle, M.D.

Independent Director

487.81K

Dr. Matthew P. Del Giudice

Director

Mr. Ned Macpherson

Director

Mr. Matthew Pratt Whalen, CPA

Director

Mr. Alan Weichselbaum

Chief Financial Officer

収益内訳

データなし

データなし

事業別

地域別

データなし

株主

更新時刻: Fri, May 16

株主統計

種類

株主統計

比率

Bay Shore Trust

22.62%

McNulty (Brian Patrick)

6.31%

The Vanguard Group, Inc.

4.23%

BlackRock Institutional Trust Company, N.A.

3.76%

Aminov (Erez)

3.39%

Other

59.69%

株主統計

比率

Bay Shore Trust

22.62%

McNulty (Brian Patrick)

6.31%

The Vanguard Group, Inc.

4.23%

BlackRock Institutional Trust Company, N.A.

3.76%

Aminov (Erez)

3.39%

Other

59.69%

種類

株主統計

比率

Corporation

22.62%

Individual Investor

11.55%

Investment Advisor

9.09%

Investment Advisor/Hedge Fund

2.98%

Research Firm

0.29%

Pension Fund

0.07%

Bank and Trust

0.07%

Other

53.33%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

13.89M

46.68%

+947.95K

2025Q1

13.90M

46.70%

+955.11K

2024Q4

13.75M

46.22%

+2.38M

2024Q3

14.68M

49.58%

+3.19M

2024Q2

12.97M

43.79%

+1.79M

2024Q1

12.67M

42.78%

+1.58M

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Bay Shore Trust

6.73M

22.62%

-89.00K

-1.30%

Dec 31, 2024

McNulty (Brian Patrick)

1.88M

6.31%

-49.00K

-2.54%

Dec 31, 2024

The Vanguard Group, Inc.

1.26M

4.23%

-10.56K

-0.83%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

1.12M

3.76%

+119.04K

+11.91%

Mar 31, 2025

Aminov (Erez)

1.01M

3.39%

+979.88K

+3288.20%

Dec 31, 2024

Eagle (Craig)

487.81K

1.64%

Dec 31, 2024

Geode Capital Management, L.L.C.

429.25K

1.44%

+15.57K

+3.77%

Mar 31, 2025

Northern Trust Investments, Inc.

151.10K

0.51%

-525.00

-0.35%

Mar 31, 2025

State Street Global Advisors (US)

125.67K

0.42%

+9.88K

+8.53%

Mar 31, 2025

Suncoast Equity Management, LLC.

51.19K

0.17%

Mar 31, 2025

詳細を見る